Zimmer Q3 profit advances on higher sales of hip, knee joints

Analysts say the firm is grabbing market share, positioning it to recover income lost due to the pandemic-driven decline in elective procedures.

By Peter Green • Nov. 3, 2022

iRhythm narrowed loss in Q3 on higher sales of cardiac wearables

Revised CMS reimbursement rates may boost the earnings potential for the company’s wearable heart monitors.

By Peter Green • Updated Nov. 4, 2022

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

BioIntelliSense adds skin-color sensitivity to pulse oximeter chips amid FDA concerns over fingertip devices

An IT-driven blood-oxygen meter may help reduce a racial disparity in care caused by erroneous readings.

By Peter Green • Updated Nov. 2, 2022

J&J to buy heart device maker Abiomed for $16.6B in year’s largest medtech deal

J&J will gain Abiomed’s heart pump devices amid a booming cardiac care market.

By Elise Reuter • Updated Nov. 2, 2022

OTC hearing aid maker Nuheara gets 510(k) clearance for HP-branded device, undercuts Lexie, Sony on price

Nuheara is betting that the combination of its technology and the HP brand will enable its product to claim a slice of the market.

By Nick Paul Taylor • Nov. 1, 2022

Hologic quarterly sales beat forecast even as demand for COVID tests wanes

The company expects its surgical and breast health businesses to rebound in fiscal 2023.

By Nick Paul Taylor • Nov. 1, 2022

Stryker sales growth limited by hospital staffing, ‘soft’ installations of Mako robot

Mako installations were “soft” because of “delays stemming from variability in the hospital environment.”

By Nick Paul Taylor • Nov. 1, 2022

Brain surgery may get boost from new steerable catheter using minimally invasive robot

The steerable needle could help surgeons more accurately reach the deep, delicate parts of the brain than existing rigid catheter technologies.

By Nick Paul Taylor • Oct. 31, 2022

Researchers develop light-based sensor to overcome diagnostic limitations of electrodes

The technology could enable “ultra-miniature” interfaces for heart and nerve devices both in clinical diagnostics and laboratory research.

By Nick Paul Taylor • Oct. 31, 2022

FDA breakthrough device designations fall in Q3 but record year still within reach

If activity accelerates after the summer months, the agency will post another record year for designations.

By Nick Paul Taylor • Oct. 31, 2022

Dexcom Q3 profit surges as CGM maker prepares for G7 launch in U.S.

Dexcom has a “compelling series of catalysts” over the next year that can accelerate growth, analysts say. 

By Elise Reuter • Oct. 28, 2022

Edwards says it expects sales to stall in Q4 as hospital staff shortages stymie TAVR growth

The company has heard reports it may take hospitals “up to a year or two” to resolve the staffing situation.

By Nick Paul Taylor • Oct. 28, 2022

ResMed quarterly profit rises on AirSense sales; CEO skeptical about timeline of Philips’ return to market

CEO Mick Farrell says he’s “not optimistic” rival Philips will be back on the market in January “given all the issues that are there for them.”

By Nick Paul Taylor • Oct. 28, 2022

Baxter lowers 2022 earnings forecast, citing supply chain, foreign-exchange pressures

The company took a $3.1 billion impairment charge in the third quarter related to its acquisition of connected care firm Hillrom in December 2021.

By Elise Reuter • Oct. 27, 2022

Baxter warns hospitals to stop using connected incontinence pads over interference risk

The interference may affect insulin pumps, fetal monitors, telemetry devices, bladder scanners and infusion pumps.

By Nick Paul Taylor • Oct. 27, 2022

Intuitive starts $1B accelerated stock repurchase, boosting recovery of share price

The move shows the robotic surgery maker “remains committed to returning cash to shareholders,” analysts said.

By Nick Paul Taylor • Oct. 27, 2022

Philips’ respirator recall troubles open door for rival ResMed, analysts say

Without a clear date for re-entering the market for sleep apnea devices, the company risks losing ground permanently to its competitor.

By Peter Green • Oct. 26, 2022

Medtech M&A decline poised to continue in 2023 amid ‘bumpy’ market: report

Dealmaking has dropped as companies grapple with surging inflation and decreased spending by hospitals, according to EY.

By Elise Reuter • Oct. 26, 2022

Boston Scientific exceeds Q3 revenue growth forecast on heart devices; profit sinks on R&D costs

Sales of the company's Watchman devices grew 26% in the period.

By Elise Reuter • Oct. 26, 2022

3M healthcare sales growth curbed in Q3 by hospital staffing shortages ahead of unit spinoff

The division remains set for a divestment in 2023 even as it struggles to gain momentum and sales slow on a drop in demand for surgical products. 

By Nick Paul Taylor • Oct. 26, 2022

GE HealthCare revenue rose 6% in Q3 as supply chain woes ease

The medtech company says global healthcare spending is solid, particularly in Europe and Asia.

By Elise Reuter • Oct. 25, 2022

BioIntelliSense buys AlertWatch, expanding Medtronic patient monitoring partnership

Medtronic will distribute AlertWatch to hospitals in the U.S. alongside BioIntelliSense’s wearable device for continuous remote monitoring.

By Nick Paul Taylor • Oct. 25, 2022

Accelerate Diagnostics withdraws BD-partnered device after FDA demands 510(k) clearance

An analyst said they were “somewhat surprised” by the FDA’s decision as “Arc does not directly lead to a patient result.”

By Nick Paul Taylor • Oct. 25, 2022

Medtronic’s planned spinoff ‘doesn’t move the needle’ in growth strategy: analysts

Combining patient monitoring and respiratory intervention businesses into a separate company may not be enough to address investor concerns.

By Elise Reuter • Oct. 24, 2022

Medtronic will spin out slower-growth patient monitoring, respiratory units to focus on core businesses

The segments will form a new connected care company, allowing Medtronic to invest more resources into faster-growing areas.

By Elise Reuter • Oct. 24, 2022